GO:1990384 hyaloid vascular plexus regression

The hyaloid vascular plexus is a transient network of blood vessels that nourishes the developing lens and retina in the embryonic eye. In normal development, this plexus must be completely regressed to allow for the formation of the mature avascular vitreous and the retinal vasculature. The Gene Ontology term GO:1990384, hyaloid vascular plexus regression, captures the biological process by which this temporary vascular structure is destroyed as part of its normal progression. This process is critical for proper eye development, and its failure can result in persistent hyaloid vessels, which may cause visual disturbances. Researchers study hyaloid vascular plexus regression to understand fundamental mechanisms of vascular remodeling, programmed cell death, and extracellular matrix degradation. Fibroblast growth factors (FGFs) have been implicated in the regulation of retinal vascularization and choroidal angiogenesis, and they also play a role in the regression of the hyaloid vascular plexus. By elucidating the molecular players and signaling pathways involved, scientists aim to develop therapeutic strategies for ocular diseases characterized by abnormal vascular persistence or regression.

GO:1990384, hyaloid vascular plexus regression, is defined as the developmental process in which the hyaloid vascular plexus is destroyed as a part of its normal progression. This process is a programmed and tightly regulated event that occurs during eye development, ensuring the clearance of temporary blood vessels that supply the developing lens and retina. It involves cellular and molecular mechanisms such as apoptosis, macrophage-mediated phagocytosis, and remodeling of the extracellular matrix, ultimately leading to the regression of the hyaloid vasculature.

Hyaloid vascular plexus regression is a fundamental developmental process that ensures the formation of a clear optical path and proper retinal vascularization. Defects in this process can lead to persistent hyaloid vessels, which may cause visual impairment, cataracts, or retinal detachment. Understanding the molecular mechanisms of regression provides insights into general principles of vascular remodeling and programmed cell death, with implications for diseases characterized by abnormal angiogenesis or vascular persistence.

The following genes and proteins have been implicated in the regulation of hyaloid vascular plexus regression or related vascular processes.

The regression of the hyaloid vascular plexus is regulated by a balance of pro-angiogenic and anti-angiogenic factors. Fibroblast growth factors (FGFs) are known to be involved in choroidal angiogenesis and retinal vascularization, and their signaling can influence the stability of hyaloid vessels. Additionally, oxygen tension, macrophage recruitment, and apoptotic pathways play critical roles. The process is tightly controlled to ensure timely removal of the temporary vasculature without affecting the developing retinal vessels.

Failure of hyaloid vascular plexus regression leads to persistent hyaloid vessels, a condition that can cause visual impairment, cataracts, or retinal detachment. This is often observed in premature infants and in certain genetic syndromes. Understanding the molecular drivers of regression may offer therapeutic targets.

Retinopathy of prematurity (ROP) is characterized by abnormal retinal vascularization. Although ROP primarily involves retinal vessels, the mechanisms of vascular regression and remodeling share similarities with hyaloid regression. FGFs, which are implicated in both processes, may play a role in ROP pathogenesis.

Age-related macular degeneration (AMD) involves choroidal angiogenesis, a process in which FGFs are involved. While not directly linked to hyaloid regression, the study of developmental vascular regression can provide insights into pathological angiogenesis in AMD.

Confocal microscopy of whole-mount eyes stained with endothelial markers (e.g., PECAM1) allows visualization of the hyaloid vascular plexus and its regression over time. This method is crucial for phenotyping knockout or transgenic models.

RNA sequencing of isolated hyaloid vessels at different developmental stages can identify genes and pathways involved in regression. This approach can reveal novel regulators and confirm the role of FGF signaling.

TUNEL staining or cleaved caspase-3 immunohistochemistry can detect apoptotic cells in the regressing hyaloid plexus. These assays help quantify cell death and evaluate the effect of genetic manipulations.

Using clodronate liposomes or genetic models to deplete macrophages can test their requirement in hyaloid vessel clearance. This method links immune cells to the regression process.

Researchers studying hyaloid vascular plexus regression-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling functional validation of genes implicated in this developmental pathway.

Hyaloid vascular plexus regression (GO:1990384) is a critical developmental process that ensures the formation of a clear visual axis. Dysregulation of this process can lead to persistent hyaloid vessels and visual impairment. Research using CRISPR-based models and advanced imaging is uncovering the molecular players, such as FGFs, that orchestrate this regression. Continued investigation will not only shed light on fundamental vascular biology but also inform therapeutic strategies for ocular diseases characterized by abnormal vascular persistence or regression.